**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 135-20-6 |CUPFERRON | 100 | 205-183-2 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Limited evidence of a carcinogenic effect.Carcinogen.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
Harmful if swallowed. Causes gastrointestinal irritation with
nausea, vomiting and diarrhea. Methemoglobinemia is characterized by
dizziness, drowsiness, headache, shortness of breath, cyanosis
(bluish discoloration of skin due to deficient oxygenation of the
blood), rapid heart rate and chocolate-brown colored blood.
Overexposure may cause methemoglobinemia.
Inhalation:
Causes respiratory tract irritation.
Chronic:
Prolonged or repeated skin contact may cause dermatitis. May cause
cancer in humans. May cause cancer according to animal studies.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Antidote:
Methylene blue, alone or in combination with oxygen is indicated as
a treatment in nitrite induced methemoglobinemia.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Wear
appropriate protective clothing to prevent contact with skin and
eyes. Wear a self-contained breathing apparatus (SCBA) to prevent
contact with thermal decomposition products. This material in
sufficient quantity and reduced particle size is capable of creating
a dust explosion.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam. Use agent most appropriate to extinguish
fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up, then place into a suitable container for disposal. Avoid
generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Do not get in eyes, on skin, or on
clothing. Avoid ingestion and inhalation.
Storage:
Keep away from heat and flame. Store in a tightly closed container.
Keep from contact with oxidizing materials. Store in a cool, dry,
well-ventilated area away from incompatible substances. Keep
refrigerated. (Store below 4C/39F.)
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Local exhaust ventilation may be necessary to control any air
contaminants to within their TLVs during the use of this product.
Exposure Limits
CAS# 135-20-6:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: light yellow or cream
Odor: none reported
pH: Not available.
Vapor Pressure: Negligible.
Viscosity: Not available.
Boiling Point: Not applicable.
Freezing/Melting Point: 163 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 159 deg C
Solubility in water: Soluble in water.
Specific Gravity/Density: Not available.
Molecular Formula: C6H9N3O2
Molecular Weight: 155.0819
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Materials containing similar functional groups can decompose at
elevated temperatures.
Conditions to Avoid:
High temperatures, incompatible materials, moisture.
Incompatibilities with Other Materials:
Strong oxidizing agents - strong acids - strong bases - moisture.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 135-20-6: NC4725000
LD50/LC50:
CAS# 135-20-6: Dermal, guinea pig: LD50 = >5 gm/kg; Draize test,
rabbit, eye: 20 mg/24H Moderate; Oral, rat: LD50 = 199 mg/kg.
Carcinogenicity:
CUPFERRON -
California: carcinogen, initial date 1/1/88
NTP: Suspect carcinogen
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Products which are considered hazardous for supply are classified as Special
Waste and the disposal of such chemicals is covered by regulations which may
vary according to location. Contact a specialist disposal company or the local
waste regulator for advice. Empty containers must be decontaminated before
returning for recycling.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, NOS
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, NOS
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, NOS
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 135-20-6: 3
Canada
CAS# 135-20-6 is listed on Canada's DSL List.
CAS# 135-20-6 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 135-20-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 2/17/1998 Revision #3 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
1-Acetyl-4-methyl-2,5-dihydro-1h-pyrrol-2-one, 97%
| 34581-92-5 |
|
Ethyl 4-acetyl-3,5-dimethyl-1h-pyrrole-2-carboxylate, 97%
| 2386-26-7 |
|
N2,N2-Diethyl-3,4,5-trimethyl-1H-pyrrole-2-carboxamide, 97%
| 58803-92-2 |
|
2-Methyl-2-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]propanoic acid,
| 175136-07-9 |
|
Triphosphopyridine Nucleotide, Sodium Salt Hydrate
| 1184-16-3 |
|
5-Bromo-4-methoxy-7-methylindane, 97%
| 175136-09-1 |
|
4-Methoxy-7-methylindane-5-carbonitrile, 97%
| 175136-10-4 |
|
2-[(7-Methyl-2,3-dihydro-1H-inden-4-yl)oxy]pyridin-3-amine, 97%
| 175136-11-5 |
|
7-Methyl-2,3-dihydro-1h-inden-4-yl acetate, 97%
| 175136-12-6 |
|
2-Bromo-3-chloro-5-(trifluoromethyl)pyridine, 97%
| 75806-84-7 |
|
Methyl 4-amino-2-methoxybenzoate, 95+%
| 27492-84-8 |
|
2-(4-Chloro-2-methylphenoxy)-3-nitropyridine, 97%
| 465514-31-2 |
|
2-(4-Chloro-3,5-dimethylphenoxy)-3-nitropyridine, 97%
| 246862-63-5 |
|
2-(2,3-Dimethylphenoxy)-3-nitropyridine, 95+%
| 76893-55-5 |
|
6,8-Dibromo-2-oxo-2h-chromene-3-carboxylic acid, 95+
| 3855-87-6 |
|
3-(5-Bromo-2-methyl-4-nitro-1H-imidazol-1-yl)propanenitrile, 97%
| 139975-78-3 |
|
Methyl 2-phenoxynicotinate, 97%
| 36701-88-9 |
|
5-Bromo-2-methyl-4-nitro-1h-imidazole, 97%
| 18874-52-7 |
|
4-(2-Methyl-4-nitro-1h-imidazol-1-yl)butan-2-one, 97%
| 126664-28-6 |
|
4-tert-Butylcatechol, 99%
| 98-29-3 |
|
3-(2-Oxocyclododecyl)propanoic acid, 97%
| 22575-75-3 |
|
2-Heptylcyclopentan-1-one oxime, 97%
| 165385-93-3 |
|
Benzo-12-crown-4, 99+%
| 14174-08-4 |
|
1-(4-Decylphenyl)ethan-1-one, 97%
| 37593-06-9 |
|
1-Bromo-4-butoxybenzene, 97%
| 39969-57-8 |
|
4-Pentylbenzene-1-sulfonyl chloride, 97%
| 73948-18-2 |
|
2-Phenyl ethyl acetate, 98+%
| 103-45-7 |
|
Norharman, 98%
| 244-63-3 |
|
Sodium iodide dihydrate, 99+%
| 13517-06-1 |
|
4-(4-Octylphenyl)-4-oxobutanoic acid, 97%
| 64779-10-8 |
|
Cupferron
| 135-20-6 |
|
4-Oxo-4-(4-propylphenyl)butanoic acid, 97%
| 57821-78-0 |
|
4-(Dihexylamino)benzoic acid, 97%
| 134690-32-7 |
|
4-Propoxybenzonitrile, 97%
| 60758-84-1 |
|
1-(4-Bromophenyl)octane, 97%
| 51554-93-9 |
|
1-(4-Bromophenyl)heptane, 97%
| 76287-49-5 |
|
1-Bromo-4-pentylbenzene, 97%
| 51554-95-1 |
|
2-Bromo-1-[3,5-di(tert-butyl)-4-hydroxyphenyl]ethan-1-one, 90+%
| 14386-64-2 |
|
3,5-Di(tert-butyl)-4-hydroxybenzonitrile, 97%
| 1988-88-1 |
|
1-Eth-1-ynyl-4-(hexyloxy)benzene, 97%
| 79887-17-5 |
|
1,3,5-Triisopropylbenzene, 97%
| 717-74-8 |
|
1-Chloro-2,6-Dibromo-4-Fluorobenzene, 99.5+%
| 0-00-1 |
|
1-Eth-1-ynyl-4-(pentyloxy)benzene, 97%
| 79887-16-4 |
|
1-Butoxy-4-eth-1-ynylbenzene, 97%
| 79887-15-3 |
|
Copper (II) Acetate Monohydrate
| 6046-93-1 |
|
1-Eth-1-ynyl-4-propoxybenzene, 97%
| 39604-97-2 |
|
Copper (II) Bromide
| 7789-45-9 |
|
1-Eth-1-ynyl-4-methoxybenzene, 97%
| 768-60-5 |
|
1-Ethynyl-4-heptylbenzene, 95%
| 79887-12-0 |
|
Copper (II) Carbonate Basic Monohydrate
| 12069-69-1 |
|
|